This document provides information about the 13th International Forum on Mood and Anxiety Disorders, which will be held from November 20-22, 2013 in Monaco. It includes the dates to remember, contact information for the organizing secretariat and venue, an overview of the program, the advance scientific program with session titles and speaker information, information on scientific submissions and registration, and forms to register and book accommodations. The forum will focus on topics related to mood and anxiety disorders, including lithium treatment, comorbidities of pain, anxiety and depression, cognition as a treatment target, treatment-resistant depression, and more.
Presentazione a cura del Professor Pasquale Abete - XII° Congresso Nazionale FIMeG 2018 - The Silver Tsunami: l'anziano fra appropriatezza e farmaeconomia
Presentazione a cura del Professor Pasquale Abete - XII° Congresso Nazionale FIMeG 2018 - The Silver Tsunami: l'anziano fra appropriatezza e farmaeconomia
3º Congreso Internacional sobre Neurobiología. Guía de tratamiento de psicofa...infobipolar
Programa Científico del 3º Congreso Internacional sobre Neurobiología. Guía de tratamiento de psicofarmacología clínica Más información en www.puedoser.es
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
3. Dates to Remember 2
Chairman 4
Co-Chairman
Scientific Advisers
Welcome Letter 4
Programme Overview 5
Advance Scientific Programme 6
Scientific Information 11
Registration and Payment 13
Hotel Accommodation and Payment 14
General Information 15
Cut out Forms: 17
Registration Form
Hotel Accommodation Form
Forms available on internet:
www.ifmad.org
CONTENTS
4. Chairman
Siegfried Kasper (Austria)
Co-Chairman
Stuart A. Montgomery (United Kingdom)
Scientific Advisers (invited)
C. Allgulander (Sweden), C.A. Altamura (Italy), C. Arango (Spain),
D. Baldwin (United Kingdom), B. Bandelow (Germany), M. Bauer (Germany),
P. Boyer (Canada), G.B. Cassano (Italy), K. Demyttenaere (Belgium),
J. Den Boer (The Netherlands), T. Dinan (Ireland), E. Eriksson (Sweden),
N. Fineberg (United Kingdom), T. Higuchi (Japan), S.H. Kennedy (Canada),
D. Lecic Tosevski (Serbia), J.P. Lépine (France), M. Maj (Italy), A.A. Mathé (Sweden),
J. Mendlewicz (Belgium), H.J. Möller (Germany), S. Pallanti (Italy),
G. Papadimitriou (Greece), G. Papakostas (USA), Z. Rihmer (Hungary),
T. Roth (USA), A. F. Schatzberg (USA), I. Schweitzer✝ (Australia), A. Serretti (Italy),
D.J. Stein (South Africa), T. Svensson (Sweden), T. Suppes (USA), E. Vieta (Spain),
D. Winkler (Austria), S. Yamawaki (Japan), A. Young (UK), J. Zohar (Israel)
SCIENTIFIC COMMITTEE
WELCOME LETTER
Siegfried Kasper, Chairman Stuart A. Montgomery, Co-Chairman
To all prospective delegates,
The International Forum on Mood and Anxiety Disorders (IFMAD) will be held from
20 to 22 November 2013 in Monte-Carlo, Monaco.
The most useful feature about IFMAD meetings is that current clinical hot topics and new
data are presented in a balanced format, adequately dissected and discussed in a collegiate
atmosphere, and digested over dinner.
The meetings are always enjoyable and informative and along with the usual updates on new
treatments this year’s IFMAD will be an efficient way of catching up with the latest developments.
This year topics that will be addressed include the following: lithium medicine or myth, the
hurtful brain, cognition as a treatment target in mood disorders, depression and cognitive and
negative symptoms in schizophrenia, treatment resistant depression, treatment of MDD.
We invite you to join us again in November 2013 to give you the opportunity to keep abreast
of the latest advances.
It will be our pleasure to welcome you in Monte-Carlo.
5. PROGRAMME OVERVIEW
Wednesday,
November 20
Thursday,
November 21
Friday,
November 22
NB: This agenda is subject to change
5
09.00/10.30
SO 03 Recovery -
the new treatment goal
in depression? - A debate
13.30/15.00
SO 05 Cognitive dysfunction
in major depressive disorder
- patient perceptions and
objective measures
15.00/16.30
SO 06 Depression, cognitive
and negative symptoms
in schizophrenia: Underlying
neurobiology and novel leads
for pharmacological
treatment
16.00/16.30
Coffee break
16.30/16.45
Coffee break
11.00/12.30
SO 04 Cognition as a treatment
target in mood disorders
16.30/18.00
SO 02 The hurtful brain
14.30/16.00
SO 01 Lithium medicine
or myth
18.00/19.00
Opening Ceremony
16.30/16.45
End of meeting
09.00/10.30
SO 08 The multidimensional
aspects of Bipolar I disorder -
the importance of
subsyndromal symptoms
11.00/12.30
SO 09 Treatment
resistant depression
13.30/15.00
SO 10 Treatment of MDD
15.00/16.30
SO 11 Hot topics
10.30/11.00
Coffee break
12.30/13.30
Lunch
12.30/13.30
Lunch
10.30/11.00
Coffee break
16.45/18.15
SO 07 Adherence
with treatment
18.15/19.15
Meet the Expert
6. WEDNESDAY, 20 November 2013
14.30-16.00 SO 01 LITHIUM MEDICINE OR MYTH
14.30-15.00 SO 0101 Lithium in acute treatment of bipolar disorder
Rasmus LICHT (Denmark)
15.00-15.30 SO 0102 Bipolar maintenance treatment
Heinz GRUNZE (United Kingdom)
15.30-16.00 SO 0103 Lithium: Still the gold standard for augmenting
antidepressants?
Timothy DINAN (Ireland)
➤ Please note that a 5’ discussion with the speaker is foreseen at the end of each presentation.
16.00-16.30 Coffee break
16.30-18.00 SO 02 THE HURTFUL BRAIN
16.30-17.00 SO 0201 The comorbidity of pain,
anxiety and depression
Hans-Ulrich WITTCHEN (Germany)
17.00-17.30 SO 0202 Explaining the co-occurrence of pain,
anxiety and depression
Johan DEN BOER (The Netherlands)
17.30-18.00 SO 0203 Psychotropics as treatments for pain
Michael BACH (Germany) - invited
➤ Please note that a 5’ discussion with the speaker is foreseen at the end of each presentation.
18.00-19.00 Opening Ceremony
ADVANCE SCIENTIFIC PROGRAMME
6
7. 7
ADVANCE SCIENTIFIC PROGRAMME
THURSDAY, 21 November 2013
09.00-10.30 SO 03 RECOVERY – THE NEW TREATMENT
GOAL IN DEPRESSION? – A DEBATE*
Sponsored by an unrestricted educational grant
of H. Lundbeck A/S
10.30-11.00 Coffee break
11.00-12.30 SO 04 COGNITION AS A TREATMENT
TARGET IN MOOD DISORDERS
11.00-11.30 SO 0401 The treatment of cognitive impairment in OCD
Naomi FINEBERG (UK)
11.30-12.00 SO 0402 The treatment of cognitive deficits in MDD
David BALDWIN (UK)
12.00-12.30 SO 0403 Cognitive deficits in bipolar disorder
Eduard VIETA (Spain)
➤ Please note that a 5’ discussion with the speaker is foreseen at the end of each presentation.
12.30-13.30 Lunch
13.30-15.00 SO 05 COGNITIVE DYSFUNCTION IN
MAJOR DEPRESSIVE DISORDER - PATIENT
PERCEPTIONS AND OBJECTIVE MEASURES*
Sponsored by an unrestricted educational grant
of H. Lundbeck A/S
* Titles are subject to change
8. 8
ADVANCE SCIENTIFIC PROGRAMME
15.00-16.30 SO 06 DEPRESSION, COGNITIVE AND NEGATIVE
SYMPTOMS IN SCHIZOPHRENIA: UNDERLYING
NEUROBIOLOGY AND NOVEL LEADS FOR
PHARMACOLOGICAL TREATMENT
15.00-15.30 SO 0601 Do depressive cognitive and negative symptoms
impact on outcome in schizophrenia?
Hans-Juergen MOELLER (Germany)
15.30-16.00 SO 0602 Neurobiological mechanisms and novel targets
for cognitive improvement
Torgny SVENSSON (Sweden)
16.00-16.30 SO 0603 Antidepressant drugs in schizophrenia and
antipsychotic drugs in depression: basic and clinical perspective
Siegfried KASPER (UK)
➤ Please note that a 5’ discussion with the speaker is foreseen at the end of each presentation.
16.30-16.45 Coffee break
16.45-18.15 SO 07 ADHERENCE WITH TREATMENT
16.45-17.15 SO 0701 Compliance counselling in bipolar disorder
Carla TORRENT (Spain)
17.15-17.45 SO 0702 The treatment of cognitive deficits in MDD
Hans-Peter VOLZ (Germany)
17.45-18.15 SO 0703 Are any drug formulations inherently better
for both adherence and effectiveness?
Carlo ALTAMURA (Italy)
➤ Please note that a 5’ discussion with the speaker is foreseen at the end of each presentation.
18.15-19.15 MEET THE EXPERT SESSION
Siegfried KASPER (Austria)
Stuart MONTGOMERY (UK)
Limited number of seats
9. 9
ADVANCE SCIENTIFIC PROGRAMME
FRIDAY, 22 November 2013
09.00-10.30 SO 08 - THE MULTIDIMENSIONAL ASPECTS
OF BIPOLAR I DISORDER - THE IMPORTANCE
OF SUBSYNDROMAL SYMPTOMS*
Sponsored by an unrestricted educational grant
of H. Lundbeck A/S
10.30-11.00 Coffee break
11.00-12.30 SO 09 - TREATMENT RESISTANT
DEPRESSION
11.00-11.30 SO 0901 Is resistant depression a signal for bipolar
disorder?
Alessandro SERRETTI (Italy)
11.30-12.00 SO 0902 My preferred treatments in TRD
Stuart A. MONTGOMERY (UK)
12.00-12.30 SO 0903 New finding in resistant depression -
focus on anxiety comorbidity
Joseph ZOHAR (Israel)
➤ Please note that a 5’ discussion with the speaker is foreseen at the end of each presentation.
12.30-13.30 Lunch
* Titles are subject to change
10. 10
ADVANCE SCIENTIFIC PROGRAMME
13.30-15.00 SO 10 - TREATMENT OF MDD
13.30-14.00 SO 1001 The effect of comorbid anxiety on outcomes
in MDD
Borwin BANDELOW (Germany)
14.00-14.30 SO 1002 Does being elderly alter response in MDD?
Cornelius KATONA (UK)
14.30-15.00 SO 1003 Double standards when evaluating the evidence
base for CBT and pharmacological treatment, respectively:
a critical analysis of guidelines from NICE and other bodies
Elias ERIKSSON (Sweden)
15.00-16.30 SO 11 - HOT TOPICS
15.00-15.30 SO 1101 Behavioural Addictions in adult ADHD
Pierre-Michel LLORCA (France) - invited
15.30-16.00 SO 1102 Rapid Antidepressant Effects of
Sleep Deprivation Therapy: Clock Genes
and Circadian Rhythms
Dietmar WINKLER (Austria)
16.00-16.30 SO 1103 Neuropeptide Y and CRH in MDD
Alex MATHE (Sweden)
16.30-16.45 End of meeting
11. • Audio-Visual Facilities:
Equipment for computerised Power Point presentation will be provided during the
scientific sessions. Power Point presentations, CD-Rom or USB keys can be viewed
and tested prior to presentation in the Slide preview room, but must be handed over
to the Slide preview room technicians at least forty minutes before the beginning of
the sessions and collected directly by the speakers immediately following their ses-
sion. It is essential for the smooth running of the sessions that all Speakers hand in
their presentation in due time.
• European Accreditation:
European Accreditation with UEMS (European Union of Medical Specialists) has been
requested for this programme.
• Certificate of Attendance:
A certificate of attendance will be sent by e-mail to all participants at the end of the
Forum.
• Posters:
Abstracts will be selected for poster display by the Scientific Secretariat. Posters (at a
maximum height of 150 cm and 90 cm base) will be displayed in the Congress area of
the Fairmont Hotel from Wednesday, 20 November 2013 to Friday, 22 November 2013.
Posters should be attended by the authors themselves who must be registered, in order
to view and discuss them during lunchtime and coffee breaks. Poster material must be
prepared in advance and should be large enough to be viewed at a distance of 2 m.
Drawings and charts should be clear and simple.
• Call for Abstracts
Deadline for submission: 13 September 2013
SUBMISSION OF ABSTRACTS
Authors presenting abstracts must be registered participants. Posters will not be
displayed from unregistered authors. The corresponding author should be identified.
The posters will be published (if accepted) in an International Journal and will be
listed alphabetically accordingly to the identified presenting author on the on line
submission.
Abstracts, which must be written in English, should be submitted electronically no
later than 13 September 2013 to: www.ifmad.org
Should you not have Internet access, please contact the Organizing Secretariat
(+377 97 97 35 55).
11
SCIENTIFIC INFORMATION
12. 12
SCIENTIFIC INFORMATION
• Abstracts may only be submitted exclusively online via the congress website.
• Abstracts must be submitted on or before the closing date, 13 September 2013. The
organisers reserve the right to reject any abstract for failure to comply with submission
instructions mentioned on the congress website. Please note that late submissions will
not be considered.
• It is possible to submit more than one abstract. However, only one presenting author per
abstract is permitted.
• Please ensure that your abstract does not contain spelling, grammatical or scientific errors.
No corrections are possible after the submission deadline. The abstract will be reproduced
exactly as submitted. No proofreading will be done.
• The presenting author must accept full responsibility for the content, submission and
presentation of the abstract, and retain full copyright of their abstract and presentation.
By submitting an abstract, authors give consent and authorise the organisers to publish or
submit for publication their abstract, presentation, picture and biography, and to include
them in any congress printed or electronic publications.
• Submitters can go back and make changes to an abstract submitted when it is as a draft
copy until the deadline. However, please note that finalized abstracts can not be edited
after approving the drafts.
• Notification on acceptance of the abstract(s) will be e-mailed by 20 September 2013 and
authors must register for the congress and pay the registration fee before 30 September
2013 in order to benefit from the early fee and confirm their presentation. Failure to do this
could result in losing your presentation.
• Acknowledgement of receipt of the submission will be sent to the stated mail address
under section “Personal details”.
• The corresponding author will receive all correspondence concerning the abstract and is
responsible for informing the other authors of the status of the abstract.
• Conflict of Interest/Disclosure: Work submitted for presentation must include an acknowled-
gement of any commercial funding sources. Authors should declare all commercial interests.
• All studies must have been approved by institutional committees on ethics of experimental
and human investigations.
• Abstracts should be written in English and the complete abstract must not exceed the box
space (320 words).
• Structured abstracts are mandatory stating clearly the Background/Aims, Methods,Results
and Conclusions.
• We recommend that you prepare your text in a word processing programme (e.g. Microsoft
Word) and then copy-paste the final text into the online abstract submission form
• It is the author’s responsibility to submit a correct abstract. Any errors in spelling, grammar
or scientific fact may be reproduced as typed by the author, if accepted.
• Changes to abstracts can only be accepted up until the deadline using your Personal Page.
• If you have any questions regarding abstracts please contact: ifmad@publicreations.com
Abstract Submission for Poster Presentations
13. Registration
Registrations can be made directly through our website www.ifmad.org, (on-line payment
by credit card is in a secure certificate mode) or by filling up the Registration Form
enclosed in this programme.
An invoice, that will serve as a confirmation letter of registration, will be sent to all
delegates upon receipt of their payment.
Please register as early as possible in order to benefit from the Early Registration Fee.
Follow the instructions below and use the Registration Form, enclosed in this programme.
The lower rate will be applied if your Registration Form arrives at the Organizing
Secretariat PUBLI CRÉATIONS 30 September 2013.
Please note that registration will only be confirmed once payment has been received.
Please send the Registration Form together with the payment to the following fax number:
+377 97 97 35 50, by post to: PUBLI CRÉATIONS 74, Boulevard d’Italie - MC 98000
Monte-Carlo (Monaco) or by e-mail: ifmad@publicreations.com
13
REGISTRATION AND PAYMENT
*Please, provide certification
Registration Fees (+ V.A.T. 19,6%)
FEE Early Late On site
30 September 2013
AREA 1
(Canada, North America, € 410 € 460 € 580
Europe Region, South Pacific)
AREA 2
(Mexico, Central America,
Caribbean Region, South America,
€ 330 € 375 € 480
Middle East)
AREA 3 (Africa, Asia) € 285 € 350 € 450
TRAINEES* and STUDENTS* € 180 € 235 € 300
ACCOMPANYING PERSON € 130 € 130 € 130
Meet the Expert € 30 € 30 € 30
30 September 2013
until 04 November 2013
After 04 November 2013
and on site
Registration fee includes:
• Attendance to all Scientific Sessions • Opening Ceremony • Welcome Reception
• Lunches and Refreshments during breaks • Congress kit • Entrance to the Exhibition
Accompanying fee includes:
• Welcome Reception • Lunches and Refreshments during breaks
Cancellations and Refunds:
Cancellation or modification of registration must be sent in writing to the Organizing
Secretariat Publi Créations (ifmad@publicreations.com).
Before 30 September all fees will be refunded minus 20%. All amounts will be settled after the Forum.
After 30 September no refunds will be made.
After 30 September all name changes will be invoiced € 36.
14. 14
The above rates are in Euro, are intended per night and include buffet breakfast, VAT
and service charges.
Others hotels are available upon request at: ifmad@publicreations.com
Deadline for hotel reservation is: 30 September, 2013. Requests after this date are subject
to availability.
Hotel Reservations
Reservation can be made directly through our website www.ifmag.org or using the
Hotel Accommodation Form enclosed in this programme which must be accompanied by
the relevant payment (amount of the entire lenght of stay). Rooms will be allocated on a
first come, first served basis. Confirmation of your accommodation booking (invoice) will
be sent to you upon receipt of the payment.
Cancellations and Refunds:
In case of cancellations after 30 September 2013 you will be charged 100% of the room
rate for the entire length of stay. In case of no-show, the amount paid is not refundable
and the reservation will be automatically cancelled.
Methods of payment
Payments of registration and accommodation, must be made in Euro by one of the
following methods:
• By Bank Transfer: please transfer the payment to PUBLI CRÉATIONS S.A.M.
Bank details: Bank Julius BAER (Monaco)
1, avenue des Citronniers - MC 98000 Monaco (MC)
IBAN: MC 23 1450 8000 0151 0479 3001 D18 - Bic (swift) BAERMCMC
The payment transfer should be net of all charges to our Company and it should clearly
state the “13th
International Forum on Mood and Anxiety Disorders”.
• By Credit Card: only VISA and EUROCARD/MASTERCARD are accepted. Please enter
the credit card number and the expiration date in the appropriate space on the Forms.
Please note that the payment should be net of all charges to our company.
• By Internet: www.ifmad.org. Payment by credit card is in a secure certificate mode.
Inquiries: any inquiries or request for additional information, changes or cancellation of
room reservations must be addressed directly to: Publi Créations - 74, Bd d’Italie
98000 Monte-Carlo - Monaco - Ph. +377 97973555 - Fax +377 97973550
ifmad@publicreations.com - Website: www.ifmad.org
HOTEL ACCOMMODATION AND PAYMENT
DOUBLE ROOM SINGLE USE DOUBLE ROOM
HOTEL FAIRMONT ****
€ 185 € 195
(city and garden view category)
15. The «13th
International Forum on Mood and Anxiety Disorder» will be held at the Fairmont Hotel
from 20-22 November 2013.
Admission
The participant’s name badge will be provided at the registration desk. All participants are
requested to wear the badge throughout the congress. Only badge holders will be admitted to
the appropriate sessions, exhibition and social events
Climate
Monte-Carlo’s climate is usually mild. In November the average temperature is 12° C during
the day
Congress venue
FAIRMONT MONTE CARLO - 12, avenue des Spélugues
Tel : +377 93 50 65 00 - Fax : +377 93 30 01 57
www.fairmont.com
The Fairmont Monte Carlo Hotel sets sail for modern luxury and the
pleasure of an inland cruise offering an experience of a life time. Right by
the sea, the Fairmont Monte Carlo enhances its splendid entrance hall with
an immense picture window, which allows guests to cast their eyes directly
into the Mediterranean Sea.
The Fairmont Monte Carlo Hotel is perfectly situated only a few minutes walk away from the town
center shops and services.
Electricity
The standard voltage in Monaco is 220 V.
Language
The official language of the Congress is English. No simultaneous translation will be provided.
Insurance
The Congress organizers cannot accept liability for personal injuries sustained, or for loss or
damage to property belonging to Congress participants, either during or as a result of the
Congress. Registration does not include insurance. It is strongly recommended that you take an
insurance policy of your choice as you register for the Congress and book your travel.
Letter of invitation
The Forum Secretariat will be please to send letters of invitation to any individual making such
request. A letter of invitation often facilitates the procedure of obtaining a Visa. Please
note that the letter is not a commitment on the part of the Forum to provide any financial support.
Secretariat
The secretariat desk will open on Wednesday, 20 November and stay open all through the
Congress.
15
GENERAL INFORMATION
16. 16
GENERAL INFORMATION
Transfer from / to the airport
The Nice Côte d’Azur International Airport is a major gateway to Southern Europe and only
22 kilometres from Monaco.
Comfortable and rapid travel is provided by numerous direct flights. Further information and a
list of all the airlines flying to Nice can be found at www.nice.aeroport.fr.
How to get to Monaco
• By taxi
Prices for taxi transfers from Nice Airport to Monaco or from Monaco to Nice Airport are as
follows:
- Day fares from € 90 to € 120 (one way)
- Night fares from € 95 to € 130 (one way)
Taxis are available outside the airport or can be ordered 24 hours a day on the following
telephone numbers:
❙ in Nice +33 4 93 13 78 78 ❙ in Monaco 0820 20 98 98
• By Airport Shuttle Express
The Shuttle Express bus No. 110 runs from Nice Airport, Terminal 1 and 2, every hour, from
09.00 to 21.00. The bus will take the participant directly to the Hotel Fairmont.
Departure Monaco: please check the schedule at the bus stop right outside the hotel or at
www.uk.niceairportxpress.com
• By Helicopter
Heli Air Monaco offers numerous daily connections (every 30 minutes) from Nice Airport
to Monaco – only 7 minutes away by helicopter. Upon arrival in Monaco, a complimentary
shuttle service will take you to your hotel. Please check with Heli Air for your pick-up time and
for departure at fabien@heliairmonaco.com ❙ phone +377 92 05 00 33 ❙ fax +377 92 05 00 51
❙ www.heliairmonaco.com
• Travelling by train
Rapid and SNCF express trains connect Monaco with all regions in France and all major
European cities.
Further information at French website: www.voyages-sncf.com
English website: www.tgv-europe.com
Welcome cocktail
All delegates are cordially invited to attend the Welcome Cocktail of the Forum, which will be
held on Wednesday, 20 November at 18.00 in the Galerie Crystal of the Fairmont.
17. REGISTRATION
FORM
13th
INTERNATIONAL
FORUM ON MOOD
AND ANXIETY
DISORDERS
20-22 NOVEMBER 2013
Please use CAPITAL LETTERS (send back to + 377 97 97 35 50 or ifmad@publicreations.com)
Surname Name
Private Address
Zip code City Country
Phone Fax
E-mail
Institute Address
Zip code City Country
Phone Fax
E-mail
For citizens of EEC countries Fiscal Code / V.A.T. number
Registration fee (+ V.A.T. 19,6%)
FEE Before After Late
30 September 2013
AREA 1
(Canada, North America, Europe Region, South Pacific) € 410 € 460 € 580
AREA 2
(Mexico, Central America, Caribbean Region, € 330 € 375 € 480
South America, Middle East)
AREA 3 (Africa, Asia) € 285 € 350 € 450
TRAINEES* € 180 € 235 € 300
Meet the Expert € 30 € 30 € 30
After 04 November 2013
and on site
30 September 2013
until 04 November 2013
Accompanying person ❏ € 130
* Please, provide certification
I wish to pay by:
❏ Credit Card: ❏ Visa ❏ Mastercard/Eurocard
Payment shall be made payable to PUBLI CRÉATIONS - Monte-Carlo
Card holder (Surname & First Name)
Card Number
Expiry Date Key code
❏ Bank Transfer made out to PUBLI CRÉATIONS (please enclose photocopy of bank receipt)
Bank details: JULIUS BAER (Monaco), 1, avenue des Citronniers, 98000 Monaco (MC)
IBAN MC 23 1450 8000 0151 0479 3001 D18 BIC (swift) BAERMCMC
Clearly State: “13th
INTERNATIONAL FORUM ON MOOD AND ANXIETY DISORDERS”
AUTHORISATION OF PERSONAL DATA - PUBLI CRÉATIONS SAM, as data controller and/or processor,
informs you that any personal data you provide, or any data received by third parties, will be used in
connection to your participation to the Congress and/or to provide you with information regarding any
other compatible activities organized by PUBLI CRÉATIONS SAM or by its partners. Data treatment
shall mean any operation, or set of operations, carried out with or without the help of electronic
or automated means, and must guarantee the confidentiality and security of your personal data.
The PUBLI CRÉATIONS SAM as data controller and/or processor may avail itself of its associates to
carry out any of the following procedures: press releases, communications to clients, data proces-
sing and computer-based consultation. The data can be communicated to scientific associations,
relative public or private agencies related to CME, financial and banking intermediaries, as well as
companies participating in the Congress with promotional functions compatible with the purposes
for which the data has been collected. The provision of your personal data is voluntary, but refusal
will prevent your participation in the Congress. According to the law dated December 23, 1993,
you shall have a right of access and correction of your personal data. Any requests can be addressed to
PUBLI CRÉATIONS SAM - 74, Bd. d’Italie - 98000 Monte-Carlo, MC Monaco - Fax: +377 97 97 35 50.
I authorize the treatment and communication of my personal data as described above.
SignatureDate:
❏ Congress registration ❏ Meet the Expert
€
+ € V.A.T. 19,6%
+ € 15 (Handling fees)
TOTAL €
18. Please use CAPITAL LETTERS (send back to + 377 97 97 35 50 or ifmad@publicreations.com)
Surname Name
Address
Zip code City Country
Phone Fax
E-mail
Date of arrival Date of departure
Type of room Num. of Person(s)
Special request
The above mentioned rates are per room per night including tax. Continental breakfast included.
Deadline for hotel reservation: 30 September 2013, requests after this date will be handled upon availability.
Hotel Double room single use Double room
HOTEL FAIRMONT ****
€ 185 € 195
(city and garden view category)
Deposit (equal to the price of the entire lenght of stay) Total €
❏ Hotel reservation
€
+ € 10 (Handling fees)
TOTAL €
AUTHORISATION OF PERSONAL DATA - PUBLI CRÉATIONS SAM, as data controller and/or processor,
informs you that any personal data you provide, or any data received by third parties, will be used in
connection to your participation to the Congress and/or to provide you with information regarding any
other compatible activities organized by PUBLI CRÉATIONS SAM or by its partners. Data treatment
shall mean any operation, or set of operations, carried out with or without the help of electronic
or automated means, and must guarantee the confidentiality and security of your personal data.
The PUBLI CRÉATIONS SAM as data controller and/or processor may avail itself of its associates to
carry out any of the following procedures: press releases, communications to clients, data proces-
sing and computer-based consultation. The data can be communicated to scientific associations,
relative public or private agencies related to CME, financial and banking intermediaries, as well as
companies participating in the Congress with promotional functions compatible with the purposes
for which the data has been collected. The provision of your personal data is voluntary, but refusal
will prevent your participation in the Congress. According to the law dated December 23, 1993,
you shall have a right of access and correction of your personal data. Any requests can be addressed to
PUBLI CRÉATIONS SAM - 74, Bd. d’Italie - 98000 Monte-Carlo, MC Monaco - Fax: +377 97 97 35 50.
I authorize the treatment and communication of my personal data as described above.
SignatureDate:
HOTEL
ACCOMMODATION
FORM
13th
INTERNATIONAL
FORUM ON MOOD
AND ANXIETY
DISORDERS
20-22 NOVEMBER 2013
I wish to pay by:
❏ Credit Card: ❏ Visa ❏ Mastercard/Eurocard
Payment shall be made payable to PUBLI CRÉATIONS - Monte-Carlo
Card holder (Surname & First Name)
Card Number
Expiry Date Key code
❏ Bank Transfer made out to PUBLI CRÉATIONS (please enclose photocopy of bank receipt)
Bank details: JULIUS BAER (Monaco), 1, avenue des Citronniers, 98000 Monaco (MC)
IBAN MC 23 1450 8000 0151 0479 3001 D18 BIC (swift) BAERMCMC
Clearly State: “13th
INTERNATIONAL FORUM ON MOOD AND ANXIETY DISORDERS”
19. ANNOUNCEMENT
OF NEXT FORUM
14th
International Forum
on Mood and
Anxiety Disorders
Save
the date!
will be held in Vienna,
November 2014
Please visit our website www.ifmad.org
for more information
Shutterstock®